 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Cenix Partners with US Non-Profit on Rare Disease Research
September 27, 2012
Cenix Partners with US Non-Profit on Rare Disease Research
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Tacere Said to be Looking for New Partner for HCV Drug Candidate
June 21, 2012 / Gene Silencing News - Germany's Cenix Establishes US Subsidiary to Expand R&D Capabilities
March 1, 2012 / Gene Silencing News - Cenix Inks Research Deal with Sygnis
November 17, 2011 / Gene Silencing News - Tekmira, Bristol-Myers Squibb Expand Collaboration
May 19, 2011 / Gene Silencing News - Samyang, Access Pharmaceuticals Ink RNAi-Delivery Research Deals
April 14, 2011 / Gene Silencing News